We are live on ! Find out more
JO

John Overdeck Two Sigma Investments

AUM $138B
1-Year Est. Return 41.87%
 

John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.

This Fund
S&P 500
This Quarter Est. Return
+9.67%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$42.6B
AUM Growth
-$927M
Cap. Flow
-$4.42B
Cap. Flow %
-10.38%
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$244M
2
PFE icon
Pfizer
PFE
+$234M
3
NKE icon
Nike
NKE
+$201M
4
TSLA icon
Tesla
TSLA
+$200M
5
SPGI icon
S&P Global
SPGI
+$196M

Sector Composition

Rank Sector Weight
1 Technology 15.1%
2 Healthcare 11.63%
3 Consumer Discretionary 11.09%
4 Financials 10.76%
5 Industrials 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHM icon
3251
Pultegroup
PHM
$24.6B
-29,100
Closed -$3M
PHO icon
3252
Invesco Water Resources ETF
PHO
$2.06B
-6,800
Closed -$414K
PHR icon
3253
Phreesia
PHR
$749M
-31,015
Closed -$718K
PHVS icon
3254
Pharvaris
PHVS
$2.55B
-8,198
Closed -$230K
PIII icon
3255
P3 Health Partners
PIII
$40.3M
-1,059
Closed -$74.6K
PLBC icon
3256
Plumas Bancorp
PLBC
$428M
-8,675
Closed -$359K
PLUG icon
3257
Plug Power
PLUG
$3.17B
-1,804,581
Closed -$8.12M
PLX icon
3258
Protalix BioTherapeutics
PLX
$192M
-19,600
Closed -$34.9K
PMT
3259
PennyMac Mortgage Investment
PMT
$815M
-10,153
Closed -$152K
PMTS icon
3260
CPI Card Group
PMTS
$323M
-12,938
Closed -$248K
PNW icon
3261
Pinnacle West Capital
PNW
$11.8B
-9,300
Closed -$668K
POOL icon
3262
Pool Corp
POOL
$6.83B
-4,600
Closed -$1.83M
PPA icon
3263
Invesco Aerospace & Defense ETF
PPA
$8.25B
-2,900
Closed -$267K
PRM icon
3264
Perimeter Solutions
PRM
$5.15B
-39,243
Closed -$181K
PRPL icon
3265
Purple Innovation
PRPL
$24.1M
-1,344
Closed -$34.6K
PRU icon
3266
Prudential Financial
PRU
$41.8B
-119,786
Closed -$12.4M
PRVA icon
3267
Privia Health
PRVA
$2.7B
-36,600
Closed -$843K
PRZO icon
3268
ParaZero Technologies
PRZO
$17.5M
-29,343
Closed -$20.9K
PSCE icon
3269
Invesco S&P SmallCap Energy ETF
PSCE
$108M
-11,620
Closed -$605K
PSTL
3270
Postal Realty Trust
PSTL
$693M
-22,699
Closed -$330K
PWR icon
3271
Quanta Services
PWR
$96.1B
-10,200
Closed -$2.2M
RPC
3272
Ridgepost Capital
RPC
$966M
-90,271
Closed -$923K
PXE icon
3273
Invesco Energy Exploration & Production ETF
PXE
$87.6M
-11,700
Closed -$362K
PXJ icon
3274
Invesco Oil & Gas Services ETF
PXJ
$66.3M
-18,280
Closed -$524K
PYXS icon
3275
Pyxis Oncology
PYXS
$257M
-91,563
Closed -$165K

Similar funds

John Overdeck's Q1 2024 Portfolio in Review

As of Q1 2024, John Overdeck held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.

John Overdeck withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, John Overdeck opened a new position in Pfizer worth $234M.

  • John Overdeck's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
  • John Overdeck added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
  • John Overdeck's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
  • John Overdeck fully exited Rivian in Q1 2024, selling an estimated $158M.
  • John Overdeck's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
  • John Overdeck opened 408 new positions and closed 532 in Q1 2024.
  • John Overdeck's portfolio value fell 2.1% quarter-over-quarter to $42.6B.

Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.